Gobernanza Merck & Co., Inc.

MRK

US58933Y1055

Farmacéuticos

Tiempo real estimado Cboe BZX Otros sitios de cotización 17:45:34 12/02/2026			Variación 5 días	Varia. 1 de enero.
121,35 ^USD	+1,71 %		+1,34 %	+15,30 %

17:27	MERCK & CO., INC. : recomendación de compra de Argus	ZM
13:35	Merck impulsa el tratamiento de los cánceres de vejiga y riñón con nuevos datos presentados en el Simposio ASCO GU Cancers 2026	CI

Comité Ejecutivo: Merck & Co., Inc.

Director

Funciones ocupadasDesde

Robert Davis

59 años

Chief Executive Officer	01/07/2021
President	01/04/2021

Caroline Litchfield

57 años

Director of Finance/CFO

01/04/2021

Kelly E. W. Grez

Corporate Secretary

01/02/2020

Dave Williams

57 años

Chief Tech/Sci/R&D Officer

01/08/2020

Sylvia A. Ayler

General Counsel

01/01/2021

Dalton Smart

60 años

Comptroller/Controller/Auditor

04/12/2023

Betty Larson

50 años

Human Resources Officer

01/04/2024

Jennifer Zachary

48 años

General Counsel

01/04/2018

Chirfi Guindo

60 años

Sales & Marketing

01/07/2022

Peter Dannenbaum

Investor Relations Contact

01/07/2017

Composición del Consejo de Administración: Merck & Co., Inc.

Administrador

ComitésDesde

Robert Davis

59 años

Governance Committee	08/01/2018
Finance Committee Chair	08/01/2018

Patricia Russo

73 años

Finance Committee	09/06/2011
Executive Committee	24/07/2009
Compensation Committee	02/11/2015
Governance Committee Chair	09/06/2011
Governance Committee	02/11/2015
Compensation Committee Chair
Audit Committee	15/06/2023
HR Committee	02/11/2015
Nominating Committee	02/11/2015

Tom Glocer

65 años

Compensation Committee	25/05/2016
Governance Committee Chair
Governance Committee	01/01/2021
Nominating Committee	01/01/2021
Audit Committee	25/05/2016

Risa Lavizzo-Mourey

71 años

Compensation Committee	26/05/2020
Compensation Committee Chair	20/04/2021
Governance Committee Chair	03/01/2023
Nominating Committee Chair	03/01/2023

Douglas Baker

67 años

Compensation Committee	24/03/2015
HR Committee	13/03/2013
Governance Committee
Audit Committee	24/05/2022

Surendralal Karsanbhai

57 años

Executive Committee	05/02/2021
Audit Committee	01/01/2025
Governance Committee	01/01/2025

Inge Thulin

71 años

Executive Committee	02/06/2011
Compensation Committee	01/03/2018
Governance Committee	01/03/2018

Paul Rothman

67 años

Audit Committee	01/09/2015
Compensation Committee	17/05/2024
HR Committee	17/05/2024

Kathy Warden

53 años

Audit Committee	16/03/2020
Governance Committee	22/03/2022

Pamela Craig

69 años

Governance Committee	01/09/2015
Audit Committee Chair

Christine Seidman

72 años

Audit Committee

16/03/2020

Mary Coe

58 años

Compensation Committee

Stephen Mayo

64 años

Audit Committee

12/07/2022

Últimos Nombramientos: Merck & Co., Inc.

09:45	Sanofi nombra a Belen Garijo como directora general	MT
03/02	Principales noticias del mediodía: PayPal no alcanza las estimaciones del cuarto trimestre y nombra nuevo CEO; las acciones de Palantir suben tras sólidos resultados	MT
03/02	Wall Street sube ligeramente con el foco en la avalancha de resultados; Palantir se dispara	RE
07/01	Vaxxas nombra a David Peacock, ex presidente global de vacunas de Merck, como director ejecutivo	RE
14/11	Principales Noticias del Mediodía: Merck Adquiere Cidara Therapeutics por 9.200 Millones de Dólares; Walmart Nombra a John Furner como CEO	MT
27/10/25	Organon Nombra a Joseph Morrissey como Director Ejecutivo Interino Tras Investigación sobre Irregularidades en Prácticas de Ventas	MT
17/09/25	Resumen de prensa - Financial Times - 17 de septiembre	RE

Más noticias

Antiguos Directivos y Administradores: Merck & Co., Inc.

Insider

Funciones ocupadas

DesdeHasta

James Christopher Scalet

Chief Tech/Sci/R&D Officer

03/11/2009

Samuel O. Thier

Director/Board Member

01/01/1994

03/11/2009

Dennis Erb

Corporate Officer/Principal

04/11/2009

Christopher Garland

Public Communications Contact

04/11/2009

Graeme Bell

Public Communications Contact

04/01/2007

04/11/2009

Stefan Oschmann

Corporate Officer/Principal

01/10/2005

04/11/2009

Steven Kelmar

Public Communications Contact

01/08/2006

04/11/2009

Margaret McGlynn

Corporate Officer/Principal

01/01/2006

01/11/2009

Johnnetta Betsch Cole

Director/Board Member

01/01/1994

01/03/2009

Wendy Yarno

Human Resources Officer	-	-
Sales & Marketing	01/12/1999	01/09/2008

David Anstice

Corporate Officer/Principal	01/01/2003	01/08/2008
President	01/01/2003	01/01/2006

Richard Henriques

Comptroller/Controller/Auditor	01/01/1981	01/01/2008
Corporate Officer/Principal	01/01/1981	01/01/2008

Judy Lewent

Director of Finance/CFO

01/01/1990

01/09/2007

Peter D. Löscher

Corporate Officer/Principal

01/05/2006

31/05/2007

William G. Bowen

Director/Board Member

01/01/1986

24/04/2007

Marcia Avedon

Human Resources Officer

01/01/2002

01/12/2006

Per Wold-Olsen

Corporate Officer/Principal

01/01/1974

01/10/2006

Penny M. Heaton

Chief Tech/Sci/R&D Officer

01/01/1999

01/09/2006

Joan Wainwright

Public Communications Contact

01/06/2000

01/06/2006

Larry Bossidy

Director/Board Member

01/01/1992

01/04/2006

Howard Chin

Corporate Officer/Principal

01/01/2004

31/12/2005

Michael R. Goldberg

Corporate Officer/Principal

01/01/1988

01/01/2005

Heidi Miller

Director/Board Member

01/01/2000

15/12/2004

William Daley

Director/Board Member

01/01/2000

01/01/2004

Wendy Perrow

Corporate Officer/Principal

01/01/1989

Ben Shapiro

Corporate Officer/Principal

01/09/1990

01/07/2003

Paul Howes

Corporate Officer/Principal

01/01/1998

01/06/2003

Patrick Yang

Corporate Officer/Principal

01/01/1992

01/01/2003

Linda Burns

Human Resources Officer

01/01/2002

01/01/2003

Wendy Dixon

Sales & Marketing

01/01/1996

01/11/2001

J. Carroll

Sales & Marketing

01/01/1976

01/01/2001

Beth Seidenberg

Private Equity Investor

01/07/1998

31/03/2000

Thomas A. Reed

Corporate Officer/Principal

01/09/1999

01/03/2000

Albert I. Wertheimer

Corporate Officer/Principal

01/01/1997

01/01/2000

Anne Tatlock

Director/Board Member	03/11/2009	-
Independent Dir/Board Member	04/05/2011	-

Elizabeth Hamilton Seabury Wyatt

Corporate Officer/Principal

01/01/1980

01/01/2000

Kamil Ali-Jackson

General Counsel

01/02/1990

01/07/1998

N. Coles

Corporate Officer/Principal

01/01/1992

01/01/1996

C. Boyd Clarke

Corporate Officer/Principal

01/01/1977

01/01/1996

Michael Tarnow

President

01/01/1973

Stewart John Hen

Corporate Officer/Principal

01/01/1990

Jerome C. Keller

Sales & Marketing

01/01/1986

01/01/1993

Richard Markham

Chief Operating Officer	01/01/1973	01/01/1993
President	01/01/1973	01/01/1993

Douglas J. MacMaster

Corporate Officer/Principal

01/01/1961

01/01/1992

Abraham E. Cohen

Corporate Officer/Principal

01/01/1982

01/01/1992

Julian Adams

Corporate Officer/Principal

01/01/1982

31/12/1987

Kenneth R. Nover

Corporate Officer/Principal

01/01/1974

01/01/1987

Kevin P. Brady

Comptroller/Controller/Auditor

01/01/1980

Teresa Leezer

Corporate Officer/Principal

David Popler

Corporate Officer/Principal

Michael N. Sohn

Corporate Officer/Principal

Daisy Fernandez Seebach

Corporate Officer/Principal

Robert Alonso

Corporate Officer/Principal

Maurisa Sommerfield

Chief Tech/Sci/R&D Officer	-	03/05/2011
Corporate Officer/Principal	03/05/2011	-

Al Cini

Corporate Officer/Principal

Frank Adell

Corporate Officer/Principal

David Osborne

Corporate Officer/Principal

Donald S. Parker

Corporate Officer/Principal

Rick Goulburn

Corporate Officer/Principal

Robert O. Likoff

Corporate Officer/Principal

Samantha Weber

Corporate Officer/Principal

Christopher Anderson

Corporate Officer/Principal

Arthur J. Hiller

Corporate Officer/Principal

Howard F. Solomon

Corporate Officer/Principal

Mark Penn

Corporate Officer/Principal

Steven B. Bernitz

Corporate Officer/Principal

Valentin A. Adia

Corporate Officer/Principal

Viren Mehta

Corporate Officer/Principal

Jack Khattar

Corporate Officer/Principal

Michael Derby

Corporate Officer/Principal

Cecil B. Pickett

Corporate Officer/Principal

Michele Washko

Corporate Officer/Principal

Todd F. Kirschner

Corporate Officer/Principal

Liping Fan

Corporate Officer/Principal

Zev S. Scherl

Corporate Officer/Principal

Tim Biro

Chief Operating Officer	-	-
Corporate Officer/Principal	-	26/07/2011

Ting Oei

Corporate Officer/Principal

Scott Schandler

Corporate Officer/Principal

Thomas Salzmann

Corporate Officer/Principal

David T. Molowa

Corporate Officer/Principal

Edward Rhoads

Sales & Marketing

P. Reed Maurer

Corporate Officer/Principal

Debra A. Bollwage

Corporate Secretary

Derek Hodkey

Chief Tech/Sci/R&D Officer

Jon Scanlon

Corporate Officer/Principal

Anne Clothier

Corporate Officer/Principal

Kris Venkat

Corporate Officer/Principal

Michael Giuliani

Corporate Officer/Principal

William Polvino

Corporate Officer/Principal

Anton Clarke Atwell

Corporate Officer/Principal

Timothy Noyes

Corporate Officer/Principal

Rohini Hira

Corporate Officer/Principal

Letty Z. Zemaitis

Corporate Officer/Principal

Distribución por Edad de los Ejecutivos

Paridad de género

Hombre	22
Mujer	15

De los cuales Comité Ejecutivo

Hombre	5
Mujer	5

De los cuales Directores

Hombre	9
Mujer	4

Revisiones

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Merck & Co., Inc. se especializa en el desarrollo, la producción y la comercialización de productos terapéuticos y vacunas que se venden con receta médica. Las ventas netas se desglosan por actividad de la siguiente manera: - venta de productos farmacéuticos (69,4 %): para el tratamiento de la hipertensión, la osteoporosis, la aterosclerosis, enfermedades respiratorias, bacterianas y fúngicas, oftalmológicas y urológicas, migraña aguda, pérdida de cabello en hombres, etc.; - venta de vacunas (20 %); - venta de productos para la salud animal (9,2 %); - otros (1,4 %). Las ventas netas se distribuyen geográficamente de la siguiente manera: Estados Unidos (50,3 %), Europa/Oriente Medio/África (21,8 %), América Latina (5,4 %), China (8,6 %), Japón (5,1 %), Asia/Pacífico (4,8 %) y otros (4 %).

Empleados

74.000

Sector

Farmacéuticos

Agenda

16/03 - dividendo

Más información sobre la empresa